Зрят в ДНК. Как и зачем алтайские врачи ищут мутации в раковых клетках
Зрят в ДНК. Как и зачем алтайские врачи ищут мутации в раковых клетках Amic.ru
Зрят в ДНК. Как и зачем алтайские врачи ищут мутации в раковых клетках Amic.ru
Вьетнамская женщина-врач стала послом международного фонда по борьбе с раком. Vietnam.vn
Постоянный симптом привёл мужчину к тому, что у него обнаружили рак толстой кишки. Vietnam.vn
Advocates call on Congress to bolster cancer research and prevention Dakota News Now
New UC Davis center seeks better brain tumor treatments for people and pets UC Davis Health
The addition of CDK4/6 inhibitors to endocrine therapy has changed the standard of care for patients with high-risk, early-stage estrogen receptor-positive, HER2-negative (ER+/HER2-) breast cancer by reducing the risk of recurrence. However, one patient subgroup continues to present a clinical dilemma. In current…
A blood test that aims to catch more than 50 types of cancer before symptoms appear narrowly won the backing of U.S. Food and Drug Administration (FDA) advisers Wednesday, even as several doubted it works.
Prostate Cancer Roundtable: symptoms, diagnosis, treatment & combating stigma WABE
Narjust Florez: The Questions We Ask in Cancer Research Shape the Care We are Able to Provide Oncodaily
Recognizing the Researchers and Collaborations Moving Cancer Research Forward on World Cancer Research Day - AFCR Oncodaily
Seattle doctor leads breakthrough study on prostate cancer treatment MyNorthwest.com
Oklahoma doctors highlight progress in childhood cancer treatment KOCO
The FDA approved belzutifan in combination with lenvatinib for adults with advanced renal cell carcinoma with a clear cell component following treatment with a PD-1 or PD-L1 inhibitor. The combination of belzutifan (Welireg, Merck) plus lenvatinib (Lenvima, Eisai) is indicated for adults with locally advanced or…
Double Your Impact in Support of World Cancer Research Day thanks to a $10,000 Matching Gift - Conquer Cancer the ASCO Foundation Oncodaily